How many insider declarations has Derynck Mika K filed?

Derynck Mika K has filed 5 public insider declarations with SEC (Form 4).

What is Derynck Mika K's role?

Derynck Mika K's reported role is not specified by the regulator across the filings.

Which companies does Derynck Mika K report trades for?

Derynck Mika K reports trades for Enliven Therapeutics, Inc..

What is Derynck Mika K's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 8.3M€.

← Executives ★ Sign in to follow

DM

Derynck Mika K

OFFICERF

·SEC (Form 4)

Enliven Therapeutics, Inc.

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€8m

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the detailed record of transactions filed by Derynck Mika K. Director active across 1 company, notably Enliven Therapeutics, Inc.. Cumulatively, 5 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €8.3m. Activity tracked since 4 August 2026. The latest transaction was filed on 4 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Derynck Mika K

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Enliven Therapeutics, Inc. (US)

Declarations5 total

◇

Derynck Mika K

DirectorExecutives4 Aug 2026Enliven Therapeutics, Inc.

$460,43317SEC ↗

20,491 shares@ US$22.470.011% mcap2.2% of flowCommon StockSEC:0001865125-26-000004:3

◇

Derynck Mika K

DirectorExecutives4 Aug 2026Enliven Therapeutics, Inc.

$216,68516SEC ↗

87,373 shares@ US$2.480.0050% mcap1.1% of flowCommon StockSEC:0001865125-26-000004:0

◇

Derynck Mika K

DirectorExecutives4 Aug 2026Enliven Therapeutics, Inc.

$696,89418SEC ↗

27,567 shares@ US$25.280.016% mcap3.4% of flowCommon StockSEC:0001865125-26-000004:1

◇

Derynck Mika K

DirectorExecutives4 Aug 2026Enliven Therapeutics, Inc.

$346,95517SEC ↗

23,364 shares@ US$14.850.0080% mcap1.7% of flowCommon StockSEC:0001865125-26-000004:2

▼

Derynck Mika K

DirectorExecutives4 Aug 2026Enliven Therapeutics, Inc.

$10M47SEC ↗

158,795 shares@ US$60.21340.22% mcap46.6% of flowCommon StockSEC:0001865125-26-000004:4

5 of 5 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

DM

Derynck Mika K

OFFICERF

·SEC (Form 4)

Enliven Therapeutics, Inc.

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€8m

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the detailed record of transactions filed by Derynck Mika K. Director active across 1 company, notably Enliven Therapeutics, Inc.. Cumulatively, 5 reports have been recorded. Split: 0 buy · 1 sell. Total volume traded: €8.3m. Activity tracked since 4 August 2026. The latest transaction was filed on 4 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.